Affimed NV (NAS:AFMD)
$ 3.85 0.02 (0.52%) Market Cap: 60.37 Mil Enterprise Value: 37.91 Mil PE Ratio: 0 PB Ratio: 1.95 GF Score: 43/100

Q3 2022 Affimed NV Earnings Call Transcript

Nov 15, 2022 / 01:30PM GMT
Release Date Price: $22.7 (+11.27%)
Operator

(Operator Instructions) Thank you for standing by. Welcome to today's third quarter earnings and business update conference call by Affimed MV. (Operator Instructions) Please note, this conference call is being recorded. I would now like to hand the call over to your host for today, Alex Fudukidis, Director of Investor Relations at Affimed. Please go ahead.

Alexander Fudukidis
Affimed N.V. - Head of IR

Thank you, Shannon, and thank you all for joining us for our call to today. Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today, which can be found on the Investor Relations section of our website. On the call today, we have members of our management team, including Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Angus Smith, our Chief Financial Officer. The team will be available for Q&A after the prepared remarks.

Before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot